U.S. markets close in 4 hours 33 minutes

Avid Bioservices, Inc. (CDMO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.02+0.39 (+1.52%)
As of 11:24AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close25.63
Bid25.92 x 1100
Ask26.00 x 800
Day's Range25.08 - 26.09
52 Week Range6.61 - 27.02
Avg. Volume577,714
Market Cap1.59B
Beta (5Y Monthly)2.22
PE Ratio (TTM)456.49
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-43% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Is Avid Bioservices (CDMO) A Great Long-Term Investment?
    Insider Monkey

    Is Avid Bioservices (CDMO) A Great Long-Term Investment?

    Laughing Water Capital LP, an investment management firm, published its second quarter 2021 investor letter – a copy of which can be downloaded here. A quarterly median account return of 9.5% net of fees was recorded by the fund for the second quarter of 2021, compared unfavorably to the 8.6% and 4.3% returns of the […]

  • Hedge Funds Aren’t Crazy About Avid Bioservices, Inc. (CDMO) Anymore
    Insider Monkey

    Hedge Funds Aren’t Crazy About Avid Bioservices, Inc. (CDMO) Anymore

    The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings […]

  • Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript
    Motley Fool

    Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript

    On today's call, we have Nick Green, President and CEO; Dan Hart, Chief Financial Officer; and Timothy Compton, Chief Commercial Officer. Today we will be providing an overview of Avid Bioservices' contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended April 30th, 2021.